Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02133365 · ClinicalTrials.gov registry record · NA
Atrial Fibrillation, Cardiac Symptoms, and Anxiety
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02133365 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 13 participants.
The verdict
NCT02133365, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is an investigation of a mindfulness and interoceptive exposure intervention in patients with atrial fibrillation, to decrease anxiety sensitivity, symptom burden, and atrial fibrillation recurrence.
Interventions
- BEHAVIORAL Mindfulness and Interoceptive Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02133365
The ClinicalTrials.gov registry entry for NCT02133365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness and Interoceptive Exposure is the first listed.
NCT02133365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02133365 about?
NCT02133365 is a clinical study titled "Atrial Fibrillation, Cardiac Symptoms, and Anxiety". This is an investigation of a mindfulness and interoceptive exposure intervention in patients with atrial fibrillation, to decrease anxiety sensitivity, symptom burden, and atrial fibrillation recurrence.
What is the current status of trial NCT02133365?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2014-09. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02133365?
The interventions under investigation include: Mindfulness and Interoceptive Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT02133365?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.